Immunotherapy for Infectious Diseases

Production of Igs and MAbs Targeting Infectious Diseases 95
94. Grunow R, et al. The high efficiency, human B cell immortalizing heteromyeloma CB-F7.
Production of human monoclonal antibodies to human immunodeficiency virus. J Immunol
Methods 1988; 106:257–265.
95. Buchacher A, et al. Generation of human monoclonal antibodies against HIV-1 proteins;
electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte
immortalization. AIDS Res Hum Retroviruses 1994; 10:359–369.
96. Szybalski W. Use of the HPRT gene and the HAT selection technique in DNA-mediated
transformation of mammalian cells: first steps toward developing hybridoma techniques
and gene therapy. Bioessays 1992; 14:495–500.
97. Li X, Abdi K, Mentzer SJ. Hybridoma screening using an amplified fluorescence microassay
to quantify immunoglobulin concentration. Hybridoma 1995; 14:75–78.
98. Bakkali L, et al. A rapid and sensitive chemiluminescence dot-immunobinding assay for
screening hybridoma supernatants. J Immunol Methods 1994; 170:177–184.
99. Steinitz M, Rosen A, Klein G. An improved dot immunobinding assay for screening
hybridoma supernatants. Non-purified antigen immobilized on nitrocellulose paper discs.
J Immunol Methods 1991; 136:119–123.
100. Riechmann L, et al. Reshaping human antibodies for therapy. Nature 1988; 332:323–327.
101. Adair JR, et al. Humanization of the murine anti-human CD3 monoclonal antibody OKT3.
Hum Antibodies Hybridomas 1994; 5:41–47.
102. Burton DR, Barbas CFR. Human antibodies from combinatorial libraries. Adv Immunol
1994; 57:191–280.
103. Hoogenboom HR. Mix and match: building manifold binding sites [news; comment].
Nature Biotechnol 1997; 15:125–126.
104. Winter G, Harris WJ. Humanized antibodies. Immunol Today 1993; 14:243–246.
105. Low NM, Holliger PH, Winter G. Mimicking somatic hypermutation: affinity maturation
of antibodies displayed on bacteriophage using a bacterial mutator strain. J Mol Biol 1996;
260:359–368.
106. Burton DR, Barbas CFR. Human monoclonal antibodies: recent achievements. Hosp Pract
1994; 29:111–119.
107. Knappik A, Plöckthun A. Engineered turns of a recombinant antibody improve its in vivo
folding. Protein Eng 1995; 8:81–89.
108. Pennell CA, Eldin P. In vitro production of recombinant antibody fragments in Pichia pastoris.
Res Immunol 1998; 149:599–603.
109. Verma R, Boleti E, George AJ. Antibody engineering: comparison of bacterial, yeast,
insect and mammalian expression systems. J Immunol Methods 1998; 216:165–181.
110. Tan W, Lam PH. Expression and purification of a secreted functional mouse/human chimaeric
antibody against bacterial endotoxin in baculovirus-infected insect cells. Biotechnol
Appl Biochem 1999; 30:59–64.
111. Carayannopoulos L, Max EE, Capra JD. Recombinant human IgA expressed in insect
cells. Proc Natl Acad Sci USA 1994; 91:8348–8352.
112. Hasemann CA, Capra JD. High-level production of a functional immunoglobulin heterodimer
in a baculovirus expression system. Proc Natl Acad Sci USA 1990; 87:3942–3946.
113. Nesbit M, et al. Production of a functional monoclonal antibody recognizing human colorectal
carcinoma cells from a baculovirus expression system. J Immunol Methods 1992;
151:201–208.
114. Ma JK, et al. Generation and assembly of secretory antibodies in plants [see comments].
Science 1995; 268:716–719.
115. Fiedler U, Conrad U. High-level production and long-term storage of engineered antibodies
in transgenic tobacco seeds. Biotechnology (NY) 1995; 13:1090–1093.
116. Zeitlin L, et al. A humanized monoclonal antibody produced in transgenic plants for
immunoprotection of the vagina against genital herpes. Nat Biotechnol 1998; 16:
1361–1364.